Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seksik

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Crohn'S & Colitis|February 23, 2019
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort studyG Pineton de Chambrun, B Pariente, P Seksik, et al.
The American Journal of Gastroenterology|August 28, 2025
Sub-cutaneous infliximab for perianal Crohn's disease: the BioLap-Rem multicentre study from the GETAIDM André, J Kirchgesner, D Laharie, et al.
Journal of Crohn'S & Colitis|December 14, 2020
Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAIDA Buisson, J Filippi, A Amiot, et al.
Journal of Crohn'S & Colitis|September 24, 2020
Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE]J Moreau, N Hammoudi, L Marthey, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2014
Olmesartan-associated enteropathy: results of a national surveyL Marthey, G Cadiot, P Seksik, et al.
Gut|June 6, 2015
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's diseaseE Quévrain, M A Maubert, C Michon, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Crohn'S & Colitis|February 23, 2019
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort studyG Pineton de Chambrun, B Pariente, P Seksik, et al.
The American Journal of Gastroenterology|August 28, 2025
Sub-cutaneous infliximab for perianal Crohn's disease: the BioLap-Rem multicentre study from the GETAIDM André, J Kirchgesner, D Laharie, et al.
Journal of Crohn'S & Colitis|December 14, 2020
Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAIDA Buisson, J Filippi, A Amiot, et al.
Journal of Crohn'S & Colitis|September 24, 2020
Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE]J Moreau, N Hammoudi, L Marthey, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2014
Olmesartan-associated enteropathy: results of a national surveyL Marthey, G Cadiot, P Seksik, et al.
Gut|June 6, 2015
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's diseaseE Quévrain, M A Maubert, C Michon, et al.
Pageof 4